0000899243-17-019200.txt : 20170727
0000899243-17-019200.hdr.sgml : 20170727
20170727174911
ACCESSION NUMBER: 0000899243-17-019200
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170725
FILED AS OF DATE: 20170727
DATE AS OF CHANGE: 20170727
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PATRICK DEVAL L
CENTRAL INDEX KEY: 0001053466
STANDARD INDUSTRIAL CLASSIFICATION: AIR TRANSPORTATION, SCHEDULED [4512]
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37539
FILM NUMBER: 17987276
MAIL ADDRESS:
STREET 1: BAIN CAPITAL, LLC
STREET 2: 200 CLARENDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Global Blood Therapeutics, Inc.
CENTRAL INDEX KEY: 0001629137
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274825712
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 EAST JAMIE COURT, SUITE 101
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650741-7700
MAIL ADDRESS:
STREET 1: 400 EAST JAMIE COURT, SUITE 101
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-07-25
0
0001629137
Global Blood Therapeutics, Inc.
GBT
0001053466
PATRICK DEVAL L
C/O GLOBAL BLOOD THERAPEUTICS, INC.
400 EAST JAMIE COURT, SUITE 101
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Common Stock
2017-07-25
4
M
0
12053
3.40
A
12053
D
Common Stock
2017-07-25
4
M
0
15000
18.85
A
27053
D
Common Stock
2017-07-25
4
S
0
27053
29.69
D
0
D
Employee Stock Option (right to buy)
3.40
2017-07-25
4
M
0
12053
0.00
D
2025-04-08
Common Stock
12053
9375
D
Employee Stock Option (right to buy)
18.85
2017-07-25
4
M
0
15000
0.00
D
2026-06-15
Common Stock
15000
0
D
25% of the shares subject to this option vested and became exercisable on April 8, 2016, and the remaining shares subject to this option shall vest and become exercisable in 12 equal quarterly installments thereafter.
The shares vested and became exercisable in 12 equal monthly installments, with the first installment on July 16, 2016, subject to the recipient's continued service on the Issuer's Board of Directors. This option was subject to accelerated vesting upon a change of control of the Issuer.
/s/ Matt Krause, as Attorney-in-Fact
2017-07-27